In summary, the present study demonstrates the oncogenic role of HACE1 in glioma cells, and determines that HACE1 causes enhanced malignant phenotypes and decreased radiosensitivity of glioma cells by enhancing protein stability and IRES-mediated mRNA translation of NRF2 (Fig. 8). Here, HACE1 is linked to central nervous system cancer.